An article published in Medicine of Metabolic Diseases looks at the developments in research on the gut microbiota and examines new possibilities for management for people with type 2 diabetes.
Add A Comment
Trending
- Natera acquires Foresight Diagnostics for up to $450M (Medtech Dive)
- $4.2M CDC grant to increase colorectal cancer screening in Pennsylvania (PennState)
- Motility coding changes coming in the new year (AGA)
- Updated Crohn’s Disease Guideline Stresses Early Use of Advanced Drugs (Medscape)
- Check your final 2025 MIPS eligibility (AGA)
- Affordable Care Act subsidies appear likely to expire (Chief Healthcare Executive)
- AI scribes hold ‘transformative potential’ for improving physician burden, patient care (Healio)
- New York Gastroenterology Associates Taps Proscia for Digital Pathology (Bio.IT World)
